Bengur Bryan Privately Places Series A Preferred Stock for CoreMedica Laboratories

11/10/16

About CoreMedica Laboratories Inc.

CoreMedica Laboratories Inc. is a Kansas City-based provider of cost effective laboratory blood testing for the early detection of common diseases, management of ongoing medical treatment and other wellness screening purposes. The Company's innovative methodology uses micro sample collection of capillary blood to provide a less expensive and more reliable alternative system to traditional venous blood collection and testing. CoreMedica's customers include leading wellness screening providers, major retailers providing wellness screening kits and services, pharmaceutical companies and major medical research organizations and universities.

Bengur Bryan privately placed Series A Preferred Stock for CoreMedica in support of its future growth.

About Bengur Bryan

Bengur Bryan provides mergers and acquisitions advice, private placements of equity and debt, and financial advisory services to middle market companies in industrial growth, transportation & logistics, healthcare services, business services, consumer products & services and government services sectors. Since 1991, Bengur Bryan has helped companies raise growth capital, merge with strategic partners and achieve optimal exits for their owners.

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.

Connect with these Baltimore Professionals on LinkedIn

  • Edwin Warfield

    Editor in Chief, Warfield Digital

    Connect
  • Jean Halle

    Independent Consultant

    Connect
  • Larry Lichtenauer

    President of Lawrence Howard & Associates

    Connect
  • Newt Fowler

    Partner at Womble Carlyle, LLP

    Connect
  • David Crowley

    Owner at Develop DC

    Connect
  • Carolyn Stinson

    Stinson Marketing Group

    Connect